Congenica
Congenica is a digital health company with the world’s leading clinical decision support platform for accelerated genomic data interpretation. Congenica software enables genomic medicine by integrating genetic data into healthcare, empowering clinicians to provide life-changing answers that transform the lives of individuals, patients and their families.
Born out of pioneering research from the Wellcome Sanger Institute and the NHS, Congenica is headquartered in Cambridge, UK, with a global footprint across the US and China. The Congenica platform is validated by the pivotal Genomics England 100,000 Genomes Project and the company is the exclusive clinical interpretation partner to the NHS Genomic Medicine Service.
Genetic diseases are technically difficult to diagnose, and patients often spend years waiting for a diagnosis. Congenica convert genomic data into actionable information, expediting the process through more efficient and accurate analysis. This supports healthcare professionals in providing patients with robust diagnoses and precise, personalised care.
Amadeus contact
In the media
30th April 2019
What drives the stand out success of genomics biotech pioneer, Congenica?
15th April 2019
Next Generation Sequencing (NGS) Data Analysis Market – Outlook on Emerging Developments 2025
Some of the leading companies in the global NGS data analysis market includes Illumina Inc., Ingenuity, Station X Inc., DNAnexus SevenBridges Genomics, Genalice, Congenica, Omicia Inc., WuXiNextCODE, Bluebee, and Edico Genome. About
15th April 2019
Next Generation Sequencing (NGS) Data Analysis Market – Outlook on Emerging Developments 2025
Some of the leading companies in the global NGS data analysis market includes Illumina Inc., Ingenuity, Station X Inc., DNAnexus SevenBridges Genomics, Genalice, Congenica, Omicia Inc., WuXiNextCODE, Bluebee, and Edico Genome. About